Cargando…
Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review
Injection-site pain (ISP) is a subjective side effect that is commonly reported with the subcutaneous administration of biological agents, yet it may only be a concern to some. Multiple factors related to the product formulation, such as pH, volume and excipients, and/or to the injection process hav...
Autores principales: | St Clair-Jones, Anja, Prignano, Francesca, Goncalves, Joao, Paul, Muriel, Sewerin, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672413/ https://www.ncbi.nlm.nih.gov/pubmed/33206343 http://dx.doi.org/10.1007/s40744-020-00245-0 |
Ejemplares similares
-
Subcutaneous Administration of Bortezomib: Strategies to Reduce Injection Site Reactions
por: Kurtin, Sandra, et al.
Publicado: (2012) -
Sequence balance minimisation: minimising with unequal treatment allocations
por: Madurasinghe, Vichithranie W.
Publicado: (2017) -
Bilateral injection-site granuloma by subcutaneous administration of luteinizing hormone-releasing hormone analogue: a case report
por: Kitazawa, Riko, et al.
Publicado: (2009) -
An investigation of minimisation criteria
por: Wade, Angie, et al.
Publicado: (2006) -
Minimising byte swapping
por: Poppe, M
Publicado: (1986)